Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma
- Author(s)
- Da-Anoy, A; Kang, EY; Lee, CH; Cheasley, D; Llaurado Fernandez, M; Carey, MS; Cameron, A; Köbel, M;
- Journal Title
- International Journal of Gynecological Pathology
- Publication Type
- Online publication before print
- Abstract
- Low-grade serous carcinoma (LGSC) is an uncommon histotype of ovarian carcinoma, accounting for ~3% of cases. There is evidence that survival of peritoneal LGSC (pLGSC) is longer than that of ovarian LGSC (oLGSC). Key molecular alterations of LGSC have been established, including loss of CDKN2A and PR expression, MAPK pathway alterations, and loss of USP9X expression. We hypothesized that LGSC could be subclassified into clinically applicable molecular subtypes by a few surrogate tests similar to endometrioid carcinomas using a hierarchical decision tree based on the strength of the prognostic associations of the individual alterations. Our study included 71 LGSCs. Immunohistochemistry for CDKN2A, ER, PR, NF1, and USP9X and sequencing for KRAS, NRAS, and BRAF were performed. Our data showed the co-occurrence of key molecular alterations, and despite suggestive trends, hierarchical molecular subtyping did not provide significantly different stratification of patients according to survival in this cohort. We confirmed that patients diagnosed with pLGSC have a longer survival than high-stage oLGSC, with the intriguing observation that normal CDKN2A and PR status were associated with excellent survival in pLGSC. Therefore, CDKN2A and PR status might aid in the classification of indeterminate implants, where abnormal findings favor pLGSC over noninvasive implants. Molecular subtypes should be further evaluated in larger cohorts for their prognostic and potentially predictive value.
- Department(s)
- Laboratory Research
- Publisher's Version
- https://doi.org/10.1097/pgp.0000000000001043
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-01 04:52:53
Last Modified: 2024-08-01 05:00:54